Traynor Capital Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-37,029
| Closed | -$1.46M | – | 162 |
|
|
2016
Q4 | $1.46M | Sell |
37,029
-8,529
| -19% | -$336K | 0.97% | 26 |
|
|
2016
Q3 | $1.77M | Sell |
45,558
-5,724
| -11% | -$222K | 1.25% | 19 |
|
|
2016
Q2 | $1.93M | Sell |
51,282
-4,162
| -8% | -$156K | 1.51% | 16 |
|
|
2016
Q1 | $2.12M | Sell |
55,444
-14,838
| -21% | -$568K | 1.69% | 16 |
|
|
2015
Q4 | $3.55M | Buy |
70,282
+4,620
| +7% | +$233K | 2.55% | 9 |
|
|
2015
Q3 | $3M | Buy |
65,662
+4,607
| +8% | +$211K | 2.59% | 8 |
|
|
2015
Q2 | $3.56M | Buy |
61,055
+4,630
| +8% | +$270K | 2.97% | 8 |
|
|
2015
Q1 | $3.11M | Buy |
56,425
+5,888
| +12% | +$325K | 2.99% | 7 |
|
|
2014
Q4 | $2.54M | Buy |
+50,537
| New | +$2.54M | 2.95% | 7 |
|